The Impact of Glutamatergic Synapse Dysfunction in the Corticothalamocortical Network on Absence Seizure Generation

Beulah Leitch1

  • 1Department of Anatomy, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, Dunedin, New Zealand.

Insights

Childhood absence epilepsy (CAE) involves corticothalamocortical (CTC) circuitry dysfunction. This review explores how AMPA receptor deficits in inhibitory interneurons contribute to CAE pathogenesis and pharmacoresistance.

Area of Science:

  • Neuroscience
  • Epileptology
  • Molecular Biology

Background:

  • Childhood absence epilepsy (CAE) is a common pediatric epilepsy originating from corticothalamocortical (CTC) circuitry dysfunction.
  • Genetic factors contribute to CAE, leading to variable responses to anti-epileptic drugs, with 30% of children being pharmacoresistant.
  • Dysfunction in AMPA receptor-mediated excitation of feed-forward inhibition (FFI) within the CTC network is implicated in absence seizure generation.

Purpose of the Study:

  • To review the impact of AMPA receptor-mediated excitation deficits in the CTC network on absence seizure generation.
  • To explore the cellular and molecular mechanisms underlying the pathogenesis of childhood absence epilepsy.
  • To discuss the role of glutamatergic synapse dysfunction in CAE.

Main Methods:

  • Literature review focusing on AMPA receptor function and dysfunction in epilepsy models.
  • Analysis of genetic mutations affecting AMPA receptor trafficking and subunits (stargazin, Gria4).
  • Examination of the role of parvalbumin-positive (PV+) inhibitory interneurons in the somatosensory cortex and thalamus.

Main Results:

  • Defects in AMPA receptor insertion into synapses of PV+ inhibitory interneurons, as seen in the stargazer mouse model (stargazin mutation), lead to absence seizures.
  • Mutations in the Gria4 gene, encoding the GluA4 AMPA receptor subunit prevalent in cortical and thalamic PV+ interneurons, also result in absence seizures.
  • Glutamatergic synapse dysfunction within the CTC network is a key factor in CAE.

Conclusions:

  • AMPA receptor trafficking and subunit composition are critical for normal function of inhibitory interneurons in the CTC network.
  • Dysfunction in AMPA receptor signaling contributes significantly to the generation of absence seizures in CAE.
  • Understanding these molecular mechanisms offers potential targets for novel therapeutic strategies for pharmacoresistant epilepsy.

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
557
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
321
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
750
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
489
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.8K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
636